TPTX - Turning Point Therapeutics, Inc

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

TPTX is currently covered by 8 analysts with average potential upside of $24.81 (40.72%) backed by 56 price targets and 67 ratings. Documented since 13-May-2019. Analyst's average stock valuation to be materialised ratio is 71.16% with an average time for price targets to be met of 95.09 days.

Most recent stock forecast was given by ANDREW BERENS from LEERINK on 13-Jun-2022.

Highest price target for TPTX is 90, Lowest price target is 31, average price target is 60.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

76

$-0.01 (-0.01%)

127

9 months 10 days ago

5/5 (100%)

$9.35 (17.11%)

34

Hold

72

$-4.01 (-5.28%)

80

9 months 10 days ago

1/2 (50%)

$7.36 (11.96%)

256

Buy

76

$-0.01 (-0.01%)

9 months 17 days ago

6/7 (85.71%)

$28.61 (45.72%)

112

Buy

76

$-0.01 (-0.01%)

134

9 months 20 days ago

3/3 (100%)

$11.88 (20.15%)

90

Hold

45

$-31.01 (-40.80%)

75

1 years 22 days ago

2/2 (100%)

$10.94 (28.77%)

179

Show more analysts